The Indian government has asked five major pharmaceutical companies to review their performance in five major health systems across the country, as the country grapples with a major pandemic.
India’s government has set up the National Health Policy Commission (NHPC), a body charged with overseeing the implementation of the country’s landmark healthcare reform.
The commission, which was created last year, has a mandate to ensure that government-run health systems meet all the public health objectives set out by the government.
The NHPC’s interim report is due in September.
The report says the quality of Indian health care is not “adequate” and recommends that “national leaders and public servants take decisive measures to ensure the highest quality of healthcare for the people of India.”
“This report will provide a blueprint for implementation of this policy in the country,” said health minister Sushil Kumar Shinde.
“The report will help to identify and implement measures to improve the health of the people,” he added.
The commission, set up in April by Prime Minister Narendra Modi’s government, will be tasked with identifying and improving health infrastructure across the state.
In addition to the five health systems in the report, the government is also looking into how to improve health outcomes for women, children and rural areas.
It is also considering a report by the National Commission for Protection of Child Rights on the role of women in health.
The recommendations from the commission are expected to be presented to the government by October.